Imodium Liquirelief (Loperamide Hydrochloride)

Imodium Liquirelief (loperamide) acts on the gastrointestinal tract to manage diarrheal conditions.

• Acute diarrhea: decreases stool frequency and improves consistency.
• Traveler's diarrhea: provides symptomatic relief for sudden onset loose stools during travel.
• Chronic diarrhea associated with irritable bowel syndrome: helps control ongoing loose stools.
• Infectious diarrhea (non‑invasive): reduces symptom severity while the underlying infection resolves.

• Loperamide is an opioid receptor agonist that binds to μ‑opioid receptors in the myenteric plexus of the intestine. This binding reduces peristaltic activity, prolongs intestinal transit time, and enhances water and electrolyte absorption, leading to firmer stools and decreased stool frequency.

Loperamide is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Constipation: reduced bowel movements or hard stools.
• Abdominal cramps: mild to moderate discomfort in the abdomen.
• Nausea: feeling of sickness or urge to vomit.
• Dry mouth: decreased salivation.
• Dizziness: light‑headed sensation.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Severe constipation leading to bowel obstruction.
• Ileus or toxic megacolon, especially in patients with underlying colonic disease.
• Allergic reactions such as rash, pruritus, or angioedema.
• Cardiac arrhythmias in cases of overdose or drug interaction.
• Central nervous system depression when combined with other opioids.

Before using Imodium Liquirelief, consider the following safety measures.

• Allergy: do not use if you have known hypersensitivity to loperamide or any excipients.
• Infectious diarrhea: avoid in cases of bacterial enterocolitis with fever or blood in stool.
• Liver impairment: use with caution in patients with hepatic dysfunction.
• Pediatric use: not recommended for children under 2 years of age.
• Dose limits: do not exceed the maximum daily dose recommended by a healthcare professional.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Loperamide may interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) can increase loperamide plasma levels.
• P‑glycoprotein inhibitors (e.g., quinidine, ritonavir) may raise systemic exposure.
• Other opioid agonists may potentiate central opioid effects.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents may exacerbate constipation.
• Concurrent use of other antidiarrheal agents can cause excessive reduction of gut motility.
• Certain antifungal azoles (e.g., fluconazole) may modestly increase loperamide concentrations.